news biocon: Billion dollar target for biologics biz by FY22 unrealistic, but we would soon return to high growth trajectory: Kiran Mazumdar Shaw April 29, 2021
news Kiran Mazumdar Shaw: After Covid, we need to use the same Rs 35,000 cr on other diseases: Kiran Mazumdar Shaw February 2, 2021
